INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Type 2 Diabetes & Insulin Resistance desk →

1,146 studies · page 34 of 48

2018 / Randomized controlled trial

Consecutive and non-consecutive intermittent fasting showed similar hypoglycaemia rates in type 2 diabetes.

Thirty-seven adults with type 2 diabetes completed a 12-week trial testing two weekly very-low-calorie fasting days scheduled either consecutively (n=18) or non-consecutively (n=19). Fasting increased the risk of hypoglycaemia despite medication reduction (RR 2.05, 95% CI 1.17 to 3.52). However, hypoglycaemia rates did not differ significantly between consecutive and non-consecutive fasting regimens (RR 1.54, 95% CI 0.35 to 6.11).

Corley BT, Carroll RW, Hall RM, et al. Diabet Med, 2018. PMID 29405359

2018 / Open-label, non-randomized, controlled study

A remote continuous care model using nutritional ketosis significantly reduced HbA1c, body weight, and diabetes medication use at 1 year.

An open-label, non-randomized controlled study evaluated a 1-year continuous care intervention (CCI) delivering remote care, biometric feedback, and nutritional ketosis versus usual care (UC) in adults with type 2 diabetes. In the CCI group, HbA1c declined from 7.6 ± 0.09% to 6.3 ± 0.07%, weight decreased by 13.8 ± 0.71 kg, and non-metformin diabetes medication prescriptions fell from 56.9 ± 3.1% to 29.7 ± 3.0% (all P < 1.0 × 10^-16). Insulin was reduced or stopped in 94% of users, sulfonylureas were eliminated, and improvements were observed in HOMA-IR, hsCRP, and triglycerides, alongside a 10% increase in LDL-C; usual care participants had no significant biomarker or medication changes.

Hallberg SJ, McKenzie AL, Williams PT, et al. Diabetes Ther, 2018. PMID 29417495

2018 / Randomized trial

Following matched 5% weight loss, intermittent energy restriction produced a greater reduction in postprandial TAG responses than continuous energy restriction.

Twenty-seven overweight or obese adults were randomized to intermittent energy restriction (IER, n=15) or continuous energy restriction (CER) until achieving 5% weight loss, followed by 7 days of weight stabilization. There was no significant difference in time to 5% weight loss (median 59 d vs 73 d, P=0.246) or body composition changes between groups. Neither diet significantly altered postprandial glycaemia (P=0.266), and insulinaemia was reduced comparatively (P=0.903). However, IER led to a significantly greater relative reduction in postprandial TAG responses (106 to 68 mmol×360 min/l) compared to CER (117 to 130 mmol×360 min/l; P=0.045), and a trend toward a greater reduction in C-peptide (P=0.057).

Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2018. PMID 29508693

2018 / Within-subject comparative study with washout

Diet restriction alone achieved similar short-term glycemic and insulin improvements as RYGB combined with the same diet in patients with type 2 diabetes.

Ten patients with type 2 diabetes completed a 10-day supervised peri-operative-equivalent diet intervention, followed by a washout period, and then an identical diet paired with RYGB. Both interventions produced similar improvements in glucose levels, β-cell function, insulin sensitivity, and post-meal hepatic insulin resistance, alongside significant decreases in fasting and postprandial acyl ghrelin. The diet-only period led to greater improvements in basal hepatic glucose output and post-meal GIP secretion, whereas the diet plus RYGB intervention induced significantly greater increases in post-meal GLP-1, PYY, and glucagon levels.

Pop LM, Mari A, Zhao TJ, et al. Diabetes Obes Metab, 2018. PMID 29532631

2018 / Uncontrolled before-and-after intervention study

A 4-week defined plant-based diet reduced blood pressure, serum lipids, and medication usage in an outpatient clinic setting.

Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).

Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002

2018 / Randomized clinical study

Dietary fibers selectively promoted gut bacteria producing short-chain fatty acids, improving HbA1c levels in patients with type 2 diabetes.

A randomized clinical study of specifically designed isoenergetic diets paired with fecal shotgun metagenomics evaluated the effect of dietary fibers in patients with type 2 diabetes mellitus. Dietary fibers selectively promoted a specific group of short-chain fatty acid (SCFA)-producing strains while diminishing or leaving unchanged most other potential producers. Greater diversity and abundance of these fiber-promoted SCFA producers led to greater improvements in hemoglobin A1c levels, partly through increased glucagon-like peptide-1 production, and diminished bacteria producing detrimental compounds like indole and hydrogen sulfide.

Zhao L, Zhang F, Ding X, et al. Science, 2018. PMID 29590046

2018 / Crossover trial

A single 45-minute aerobic exercise session reduced postprandial glucose and insulin and improved insulin sensitivity in normal weight and overweight adolescents.

Researchers evaluated the effect of a 45-minute aerobic exercise session performed either 17 hours prior (Prior Day Ex) or 40 minutes prior (Same Day Ex) versus no exercise on postprandial glucose control following a test meal in 11 normal weight and 12 overweight/obese adolescents. Across all trials, the overweight/obese group had higher fasting glucose (~6%) and insulin (~66%), and lower insulin sensitivity (~9%) than normal weight peers. Both Same Day Ex and Prior Day Ex reduced glucose area under the curve by 6% (P < .01), reduced insulin AUC by 15% and 13% respectively (P < .03), and increased insulin sensitivity by 8% and 6% respectively (P < .01). The magnitude of these effects did not differ between normal weight and overweight/obese groups.

Short KR, Pratt LV, Teague AM Pediatr Diabetes, 2018. PMID 29687558

2018 / Supervised controlled feeding randomized crossover trial

Early time-restricted feeding improved insulin sensitivity, blood pressure, and oxidative stress without weight loss in men with prediabetes.

Researchers conducted a supervised controlled feeding trial to determine if intermittent fasting provides benefits independent of weight loss by feeding participants enough food to maintain weight. Men with prediabetes were randomized to early time-restricted feeding (a 6-hour feeding window with dinner before 3 p.m.) or a control schedule (12-hour feeding period) for 5 weeks, followed by crossover to the alternate schedule. Early time-restricted feeding improved insulin sensitivity, β cell responsiveness, blood pressure, oxidative stress, and appetite without weight loss.

Sutton EF, Beyl R, Early KS, et al. Cell Metab, 2018. PMID 29754952

2018 / Single-blinded randomized controlled trial

Flaxseed cookies improved constipation symptoms, body weight, glycemic control, and lipid levels in constipated patients with type 2 diabetes.

In a single-blinded randomized controlled trial, 53 constipated patients with type 2 diabetes received either 10 g of flaxseed pre-mixed in cookies twice daily or placebo cookies for 12 weeks. Compared with placebo, the flaxseed group showed statistically significant improvements in absolute change for constipation symptom scores (2.46 vs. 0.41), weight (-3.8 vs. 0.0 kg), BMI (-1.5 vs. -0.1 kg/m2), FPG (-26.7 vs. -1.9 mg/dl), HbA1c (-0.8 vs. 1.0%), cholesterol (-37.3 vs. -10.4 mg/dl), LDLC (-21.0 vs. -4.3 mg/dl), and HDLC (4.7 vs. -4.4 mg/dl; all P < 0.05). Compliance was reported as good, and no adverse effects were observed.

Soltanian N, Janghorbani M Nutr Metab (Lond), 2018. PMID 29760761

2018 / Randomized crossover trial

Small doses of allulose modestly reduced postprandial glucose in type 2 diabetes.

In a double-blind, multiple-crossover trial of 24 adults with type 2 diabetes, adding 10 g of allulose to a 75-g glucose drink significantly reduced plasma glucose incremental AUC by 8% (717.4 ± 38.3 vs. 777.5 ± 39.9 mmol × min/L, P = 0.015) with a linear dose response. Reductions also occurred for secondary glucose metrics at 5 g and 10 g. Fructose showed no effect at any tested dose.

Noronha JC, Braunstein CR, Glenn AJ, et al. Diabetes Obes Metab, 2018. PMID 29797503

2018 / Controlled feeding trial

Excess saturated fat increased liver fat more than unsaturated fat or simple sugars

In a controlled clinical trial, 38 overweight adults received 1,000 extra kcal per day from saturated fat, unsaturated fat, or simple sugars for 3 weeks. Intrahepatic triglyceride levels increased by 55% with saturated fat and by 15% with unsaturated fat (P < 0.05), compared to 33% with simple sugars. Saturated fat overfeeding also elevated lipolysis, insulin resistance, endotoxemia, and plasma ceramides.

Luukkonen PK, Sädevirta S, Zhou Y, et al. Diabetes Care, 2018. PMID 29844096

2018 / Intervention trial with matched historical controls

An 8-hour time-restricted feeding regimen reduced body weight, energy intake, and systolic blood pressure in obese adults compared to historical controls.

Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.

Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594

2018 / Randomized, placebo-controlled, double-blind parallel trial

In obese, insulin-resistant men, 12 weeks of nicotinamide riboside supplementation was safe but did not improve insulin sensitivity or glucose metabolism.

Forty sedentary, obese men aged 40-70 years were randomized to receive 12 weeks of nicotinamide riboside (NR, 1000 mg twice daily) or placebo. NR supplementation did not improve insulin sensitivity, endogenous glucose production, glucose disposal, or glucose oxidation. Furthermore, NR had no effect on resting energy expenditure, lipolysis, lipid oxidation, or body composition. No serious adverse events occurred and safety blood tests remained normal.

Dollerup OL, Christensen B, Svart M, et al. Am J Clin Nutr, 2018. PMID 29992272

2018 / Randomized, placebo-controlled trial

In patients with diabetes, daily n-3 fatty acid supplementation did not reduce the risk of serious vascular events over 7.4 years of follow-up.

Researchers randomly assigned 15,480 patients with diabetes and no evidence of atherosclerotic cardiovascular disease to receive daily 1-g capsules of n-3 fatty acids or an olive oil placebo. Over a mean follow-up of 7.4 years, serious vascular events occurred in 8.9% of the fatty acid group and 9.2% of the placebo group (rate ratio, 0.97; 95% CI, 0.87 to 1.08; P=0.55). The composite outcome of a serious vascular event or revascularization occurred in 11.4% and 11.5%, respectively (rate ratio, 1.00; 95% CI, 0.91 to 1.09), and all-cause death occurred in 9.7% versus 10.2% (rate ratio, 0.95; 95% CI, 0.86 to 1.05).

ASCEND Study Collaborative Group, Bowman L, Mafham M, et al. N Engl J Med, 2018. PMID 30146932

2018 / Randomised, placebo-controlled, crossover study

Curcumin, alone or with fish oil, significantly reduced postprandial glucose and insulin responses in healthy individuals.

A randomised, placebo-controlled, crossover trial examined the effects of a single dose of placebo, curcumin (180 mg), fish oil (1.2 g LC n-3 PUFA), or curcumin plus fish oil before a standard meal in 16 healthy participants across 4 test days. At 60 minutes, postprandial glucose was significantly lower with curcumin (60.6%, P = 0.0007) and curcumin plus fish oil (51%, P = 0.002). Compared to placebo, blood glucose AUC was reduced by curcumin (36%, P = 0.003) and curcumin plus fish oil (30%, P = 0.004), but not fish oil alone (P = 0.105). Postprandial insulin AUC was also significantly reduced by 26% with both curcumin (P = 0.01) and curcumin plus fish oil (P = 0.03).

Thota RN, Dias CB, Abbott KA, et al. Sci Rep, 2018. PMID 30209353

2018 / Randomized crossover trial

Moringa oleifera leaf powder added to a traditional meal lowered postprandial glycemic response in Saharawi diabetic subjects but not in healthy subjects.

On two different days, 17 Saharawi diabetic subjects and 10 healthy subjects were randomly administered a traditional meal supplemented with 20 g of Moringa oleifera (MO) leaf powder or a control meal without MO. Capillary glycaemia was measured before the meal and at 30 min intervals for 3 h. In diabetic subjects, the postprandial glucose response peaked earlier with the 20 g MO meal compared to control, showed lower increments at 90, 120, and 150 min, and had a lower mean glycemic response. No differences were seen in healthy subjects. The abstract notes poor taste acceptability of the 20 g MO meal.

Leone A, Bertoli S, Di Lello S, et al. Nutrients, 2018. PMID 30322091

2018 / Self-controlled clinical trial

Foxtail millet intake was followed by reduced blood glucose in impaired glucose tolerance

In a self-controlled clinical study, adults with impaired glucose tolerance consumed 50 g daily of foxtail millet for 12 weeks. Following the intervention, fasting blood glucose dropped from 5.7 ± 0.9 mmol/L to 5.3 ± 0.7 mmol/L (p < 0.001) and 2-hour glucose fell from 10.2 ± 2.6 mmol/L to 9.4 ± 2.3 mmol/L (p = 0.003). Circulating leptin increased (p = 0.012) while insulin resistance declined (p = 0.007).

Ren X, Yin R, Hou D, et al. Nutrients, 2018. PMID 30326632

2018 / Randomized controlled trial

A low-carbohydrate diet combined with HIIT yielded the greatest percentage improvements in glucose, cholesterol, weight, and several inflammatory markers in obese T2D patients.

Researchers randomized inactive obese patients with type 2 diabetes into three experimental diet groups (low-carbohydrate [LCD], low-fat [LFD], high-fat [HFD]; n=11 each) and a normal diet control group (n=9) over 24 weeks combining diets with 12 weeks of cycle-ergometer HIIT. After 24 weeks, the highest percentage improvements were seen in LCD for glucose (-34.76%), cholesterol (-33.35%), HDL (+41.81%), triglycerides (-40.71%), and weight (-12.49%). The highest percentage reductions in IL-6 (-32.10%), resistin (-28.29%), and leptin (-53.92%) occurred in the LCD group, while LFD showed the largest improvements in TNF-alpha (-48.06%), FGF21 (+55.30%), and adiponectin (+42.32%).

Asle Mohammadi Zadeh M, Kargarfard M, Marandi SM, et al. J Diabetes Metab Disord, 2018. PMID 30918861

2017 / Randomized, double-blinded crossover trial

A replacement diet with organic ancient khorasan wheat improved metabolic and inflammatory risk factors in type 2 diabetes patients.

In a randomized, double-blinded crossover trial, 21 patients with type 2 diabetes consumed products made from organic ancient khorasan wheat or modern organic control wheat for 8 weeks each, separated by an 8-week washout. The metabolic risk profile improved only after the khorasan intervention, with mean reductions in total cholesterol (-3.7%), LDL cholesterol (-3.4%), insulin (-16.3%), and blood glucose (-9.1%). Khorasan wheat also significantly reduced reactive oxygen species, VEGF, and interleukin-1ra, and increased total antioxidant capacity (+6.3%), whereas modern wheat produced no significant differences from baseline.

Whittaker A, Dinu M, Cesari F, et al. Eur J Nutr, 2017. PMID 26853601

2017 / Randomized controlled trial

Fresh yellow onion intake lowered fasting glucose and insulin resistance during breast cancer chemotherapy.

Eligible breast cancer patients receiving doxorubicin-based chemotherapy were randomized to an 8-week intervention with high daily onion intake (100 to 160 g/d) or low daily onion intake (30 to 40 g/d). Analyses of 23 participants per group revealed that high onion intake significantly decreased fasting blood glucose and insulin levels relative to low onion intake (P < .001). Post-treatment insulin resistance assessed by HOMA-IR was also significantly lower in the high onion group (P < .05).

Jafarpour-Sadegh F, Montazeri V, Adili A, et al. Integr Cancer Ther, 2017. PMID 27352956

2017 / Randomized double-blind placebo-controlled trial

Chlorella vulgaris supplementation affected weight and glucose changes in fatty liver disease

Seventy patients with non-alcoholic fatty liver disease were randomized to receive 1,200 mg daily of Chlorella vulgaris or placebo for 8 weeks. Weight reduction was significantly greater in the supplemented arm compared to placebo. Between-group differences in mean changes were significant for serum glucose and TNF-α after adjusting for baseline values and insulin (reported adjusted P-values: 0.014, 0.005, 0.014), but not for other measured outcomes.

Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, et al. Clin Nutr, 2017. PMID 27475283

2017 / Randomized controlled trial

Replacing diet beverages with water after lunch may lead to greater weight reduction in obese women with type 2 diabetes.

In an 81-patient randomized trial of overweight and obese women with type 2 diabetes on a weight loss program, replacing diet beverages with water after lunch 5 times per week resulted in greater decreases in weight (-6.40 ± 2.42 kg vs -5.25 ± 1.60 kg; P = .006) and BMI (-2.49 ± 0.92 kg/m2 vs -2.06 ± 0.62 kg/m2; P = .006) over 24 weeks compared to continuing diet beverages. The water group also achieved significantly greater reductions in fasting plasma glucose, fasting insulin, HOMA-IR, and 2-hour postprandial glucose. However, no significant time × group interaction was found for waist circumference, lipid profiles, or HbA1c.

Madjd A, Taylor MA, Delavari A, et al. Diabetes Obes Metab, 2017. PMID 27748014

2017 / Crossover trial

Adding 30 g of insoluble dietary fiber to a high-fat high-calorie meal reduced postprandial inflammatory and ROS responses in normal fasting subjects.

Ten normal fasting subjects consumed a high-fat, high-calorie (HFHC) meal with or without 30 g of insoluble dietary fiber across two visits, with blood sampled over 5 hours. Adding fiber significantly lowered glucose excursion in the first 90 minutes and increased insulin and C-peptide secretion over the 5-hour period compared with the meal alone. The fiber addition prevented increases in lipopolysaccharide (LPS) and significantly reduced meal-induced increases in reactive oxygen species generation, as well as the expression of IL-1β, TNF-α, TLR-4, CD14, SOCS-3, and PTP-1B.

Ghanim H, Batra M, Abuaysheh S, et al. J Clin Endocrinol Metab, 2017. PMID 27906549

2017 / Randomized crossover trial

Non-nutritive sweeteners did not reduce total daily energy intake compared with sucrose.

A randomized crossover trial in 30 healthy men compared mid-morning preloads sweetened with aspartame, monk fruit, stevia, or sucrose (65 g). Ad libitum lunch intake was higher after non-nutritive sweetener drinks than sucrose (P = 0.010), leading to full compensation and no difference in total daily energy intake (P = 0.831). Three-hour total area under the curve for glucose (P = 0.960) and insulin (P = 0.216) did not differ among the four beverages.

Tey SL, Salleh NB, Henry J, et al. Int J Obes (Lond), 2017. PMID 27956737